Table 5 Sub-group analysis of CTCs count in patients with high metastatic volume
ADT alone, n = 13 | ADT + cryosurgery, n = 9 | Z value | P value | |
|---|---|---|---|---|
Baseline, n (%) | ||||
< 2 | 0 (0%) | 0 (0%) | 0.000 | 1.000 |
2‑5 | 0 (0%) | 0 (0%) | ||
≥ 5 | 13 (100%) | 9 (100%) | ||
3 months, n (%) | ||||
< 2 | 2 (15.4%) | 1 (11.1%) | 1.596 | 0.111 |
2‑5 | 1 (7.7%) | 5 (55.6%) | ||
≥ 5 | 10 (76.9%) | 3 (33.3%) | ||
12 months, n (%) | ||||
< 2 | 4 (30.8%) | 3 (33.3%) | 1.593 | 0.111 |
2‑5 | 2 (15.4%) | 6 (66.7%) | ||
≥ 5 | 7 (53.8%) | 0 (0%) | ||